Fortrea Holdings FTRE
NASDAQ FTRE
$18.24 -0.38 (-2.04%)
As of: Sep 4, 2026 · 12:49 PM EDT

Fortrea Holdings (FTRE) Change in Accured Expenses (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Change in Accured Expenses came in at $25.1 million in Q2 2026, down 1.18% YoY from $25.4 million in Q2 2025, and up 157.83% on a QoQ basis from -$43.4 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Change in Accured Expenses (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of Change in Accured Expenses data on file, last reported at $25.1 million in Q2 2026.

  • Quarterly Change in Accured Expenses fell 1.18% year-over-year to $25.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$10.1 million (down 138.4% YoY) and the FY2025 annual result came in at $6.5 million, up 30.0% from the prior year.
  • Change in Accured Expenses advanced to $25.1 million in Q2 2026, from -$43.4 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $80.3 million in Q2 2023 to a low of -$65.1 million in Q1 2023.
  • A 5-year average of -$1.7 million and a median of -$17.6 million in 2024 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2024 — Change in Accured Expenses tumbled 96.26% — and 2025, when it surged 746.67%.
  • Tracing FTRE's Change in Accured Expenses over 5 years: stood at -$22.7 million in 2022, then soared by 253.3% to $34.8 million in 2023, then surged by 39.94% to $48.7 million in 2024, then plunged by 53.39% to $22.7 million in 2025, then advanced by 10.57% to $25.1 million in 2026.
  • The last three Change in Accured Expenses figures came in at $25.1 million (Q2 2026), -$43.4 million (Q1 2026), and $22.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn -
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - 55.78 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn - -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn 68.82 Mn
10 Fortrea Holdings 1.73 Bn 1.56 Bn 139.20 Mn 25.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.10 Mn
Mar 31, 2026 -43.40 Mn
Dec 31, 2025 22.70 Mn
Sep 30, 2025 -14.50 Mn
Jun 30, 2025 25.40 Mn
Mar 31, 2025 -27.10 Mn
Dec 31, 2024 48.70 Mn
Sep 30, 2024 -20.70 Mn
Jun 30, 2024 3.00 Mn
Mar 31, 2024 -26.00 Mn
Dec 31, 2023 34.80 Mn
Sep 30, 2023 -23.80 Mn
Jun 30, 2023 80.30 Mn
Mar 31, 2023 -65.10 Mn
Dec 31, 2022 -22.70 Mn
Sep 30, 2022 -24.00 Mn